Skip to main content
!
Phase III+: The University is open for expanded research operations; only authorized personnel will be admitted on campus. More info here.

Novel cells might act as a warning sign for rheumatoid arthritis flares

A genomics study has identified a previously unknown cell type whose blood levels tend to rise and fall in patients with rheumatoid arthritis. The findings could make it easier to manage the disease and help scientists understand its root causes.

Interview: Mary Jeanne Kreek 

Thousands of years after humans discovered opioids, we’re just beginning to understand how these substances warp the brain and change behaviors.

How Plant Operations maintained essential university functions during shutdown

For the men and women of Plant Operations, there really was no university closure. Even as most of the university’s labs shut down, those that remained still semi-operational required support.

Rockefeller tops international ranking of research impact

According to this year’s CWTS Leiden Ranking of over 1100 universities from 65 countries, Rockefeller has the highest proportion of frequently cited scientific publications.

Why memory-forming neurons are vulnerable to Alzheimer's

Scientists have used advanced technology to “micro-dissect” the first brain cells to perish in Alzheimer’s disease. The result is a short list of genes that could represent new drug targets.

If humans could hide 

The Aedes aegypti genome might hold clues for developing the most effective repellants yet—including ones that make the mosquito unable to smell us, or less motivated to seek us out.

How an adapting Child and Family Center supports the littlest learners in the pandemic

The CFC’s team has had to pivot quickly to create new online programming to support their young charges and provide age appropriate education and enrichment—and a measure of continuity.

Rockefeller statement on executive order suspending visas

The Office of the President today issued the statement below to all Rockefeller University employees. President Donald J. Trump’s ill-conceived executive order to suspend the issuing of temporary visas for foreign workers, including H1-B and J-1 visas, is detrimental to the advance of science a...

David Rockefeller Fellowship awarded to graduate student Tom Hindmarsh Sten

Hindmarsh Sten receives the university’s most prestigious graduate fellowship for his work exploring the fundamental cognitive and neurological pathways underlying courtship behavior in Drosophila.

30 young scientists receive Rockefeller Ph.D.s during virtual convocation ceremony

Since its inception, Rockefeller’s graduate program in bioscience has granted doctor of philosophy degrees to more than 1,320 students, including this year's graduates.

Recent Awards and Honors

Junyue Cao

Junyue Cao wins Science & SciLifeLab Grand Prize For Young Scientists

November 19, 2020

Cao is recognized for his work using single-cell genomic methods to enable developmental mapping of entire organisms, described in an essay published in Science.
LLuciano Marraffini portrait

Luciano Marraffini awarded Max Planck-Humboldt Medal

October 14, 2020

Marraffini receives the award for his achievements studying CRISPR-Cas, a bacterial immune mechanism whose discovery led to modern gene-editing tools.
More awards and honors

Rockefeller in the News

The New York Times

Laboratory studies from Michel Nussenzweig and others of mutations circulating in South Africa suggest they may dodge some of the body’s immune responses.

The Wall Street Journal

Researchers are working on new antibody drugs that can be given with quick jabs in the arm, similar to flu shots. They would enable patients to get treated quickly after being diagnosed with Covid-19, said Michel C. Nussenzweig, an immunologist and professor at Rockefeller University in New York.

Nature News

Evidence from Jean-Laurent Casanova and others is growing that self-attacking ‘autoantibodies’ could be the key to understanding some of the worst cases of SARS-CoV-2 infection.

Seek magazine

Rockefeller’s flagship publication is interested not just in scientific results, but in the people, ideas, and conversations that ignite discovery. The latest issue takes us inside the response to the pandemic, where scientists are using every tool in the 21st century playbook to transform COVID-19 into a manageable disease. Also: Mosquito menace, The brain inside your gut, and Addiction then and now.


From this issue

 


Subscribe to Rockefeller Science News

Did you know Rockefeller has a monthly science newsletter? Subscribe now to stay on top of the latest discoveries, news updates, and science highlights from Rockefeller’s laboratories and researchers.